Strategies based on organ decellularization and recellularization

Area of Science:

• Regenerative Medicine
• Tissue Engineering
• Transplantation Biology

Background:

• Transplantation is the sole curative treatment for end-stage organ failure, but organ scarcity limits patient access.
• Alternative strategies are urgently needed to overcome donor organ shortages and improve patient outcomes.
• Whole-organ decellularization and recellularization has emerged as a significant area of research.

Purpose of the Study:

• To review the current advancements in whole-organ decellularization and recellularization techniques.
• To identify and discuss the unresolved challenges and future directions in the field.
• To highlight the potential of creating patient-specific neo-organs.

Main Methods:

• Decellularization: Removal of cellular components while preserving the extracellular matrix (ECM) architecture.
• Recellularization: Repopulation of decellularized ECM scaffolds with patient-derived cells.
• Review of existing literature on organ de- and recellularization strategies.

Main Results:

• Decellularization successfully removes cellular material, yielding ECM bioscaffolds that retain organ-specific micro- and macro-anatomy.
• Recellularization aims to generate functional neo-organs using autologous cells, potentially negating the need for immunosuppression.
• Significant hurdles remain, particularly concerning the sourcing of suitable organs and cells for recellularization.

Conclusions:

• Whole-organ decellularization and recellularization presents a viable strategy to address organ scarcity in transplantation.
• Further research is critical to overcome current limitations in organ and cell sourcing and ensure clinical translation.
• This approach holds promise for personalized regenerative medicine and improved long-term patient survival.